期刊文献+

胎盘屏障体外模型的应用与研究进展

Application and study of in vitro modeling of the placental barrier:a review
下载PDF
导出
摘要 胎盘作为联系母体和胎儿的独特的临时性器官,在妊娠期间发育并不断改变其结构和功能。作为物质交换的场所,其对病原体、外源化合物的屏障作用也保证了胎儿的健康发育。由于物种间生理差异与人类伦理约束的影响,目前的研究还存在很多局限性。胎盘屏障体外模型的发展将为探究药物与毒物透过胎盘屏障的转运代谢过程、妊娠并发症与合并症对胎儿的影响带来更多详细信息。本文通过对胎盘灌注、滋养层细胞与组织培养、类器官、胎盘微流控芯片等模型进行评价,综述其在药理与毒理研究中的应用,提示此类模型对妊娠期药物疗效评估、胎儿宫内治疗、围产期新药开发等具临床前瞻性意义。 As a multifunctional temporary organ that connects the mother and fetus,the placenta develops during pregnancy and keeps changing its structure and function during the process.As a place for material exchange,the placenta can also help ensure the healthy development of the fetus via its barrier effect against pathogens and exogenous compounds.Due to the physiological differences between species and human ethical constraints,there are still many limitations to current research.The construction of in vitro placental barrier models has brought more detailed information on the metabo-lism of complications and comorbidities during pregnancy,and the transport of drugs and toxicants across the placental barrier.This article evaluates the placental perfusion models,trophoblast cell lines and tissue culture models,organoid models,and placental microfluidic microarrays,and summarizes their applications in pharmacological and toxicological studies.The development of these models is of clinical significance for the assessment of drug efficacy during pregnancy,intrauterine treatment of the fetus,and perinatal development of new drugs.
作者 齐子棠 宋殿荣 QI Zitang;SONG Dianrong(Graduate School of Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300250,China)
出处 《中国药理学与毒理学杂志》 CAS 北大核心 2023年第11期872-878,共7页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金(82074275)。
关键词 胎盘屏障 妊娠 类器官 体外模型 胎盘微流控芯片 placental barrier pregnancy organoid in vitro model placenta-on-a-chip
  • 相关文献

参考文献2

二级参考文献31

  • 1Gendron MP, Martin B, Oraichi D, Berard A. Health care providers' requests to teratogen information services on medication use during pregnancy and lactation [ J ]. Eur J Clin Pharmacol, 2009, 65(5) :523-531.
  • 2Panigel M, Pascaud M, Brun JL. Radioangiographic study of circulation in the villi and intervillous space of isolated human placental cotyledon kept viable by perfusion [ J ]. J Physiol ( Paris), 1967, 59(1 Suppl) :277.
  • 3Hutson JR, Garcia-Bournissen F, Davis A, Koren G. The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeu- tic drugs[J]. Clin Pharmacol Ther, 2011,90(1 ) :67-76.
  • 4Myren M, Mose T, Mathiesen L, Knudsen LE. The human placenta - an alternative for studying foetal exposure [ J ]. Toxicol In Vitro, 2007, 21 (7) :1332-1340.
  • 5Kraemer J, Klein J, Lubetsky A, Koren G. Perfusion stud- ies of glyburide transfer across the human placenta: impli- cations for fetal safety [ J ]. Am J Obstet Gynecol, 2006, 195( 1 ) :270-274.
  • 6AI-Saleh E, Nandakumaran M, AI-Rashdan I, AI-Harmi J, AI-Shammari M. Maternal-fetal transport kinetics of carbopl- atin in the perfused human placental Iobule: in vitro study [J]. J Matern Fetal Neonatal Med, 2007, 20(9) :695-701.
  • 7Hnat M, Bawdon RE. Transfer of meropenem in the ex vivo human placenta perfusion model [ J ]. Infect Dis Obstet Gynecol, 2005, 13(4) :223-227.
  • 8Nanovskaya TN, Nekhayeva IA, Patrikeeva SL, Hankins GD, Ahmed MS. Transfer of metformin across the dually per- fused human placental Iobule [ J ]. Am J Obstet Gynecol, 2006, 195(4):1081-1085.
  • 9Balakrishnan B, Henare K, Thorstensen EB, Ponnam- palam AP, Mitchell MD. Transfer of bisphenol A across the human placenta [ J ]. Am J Obstet Gynecol, 2010, 202 (4) :393. e1-e7.
  • 10The First Affiliated Hospital of Kunming Medical University. An equipment for human placental transfer studies. China.. 201120210918.0[ P], 2011-12-07.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部